Pharma
Past, present and future
Seamless commercial view of the industry
Build your understanding of the commercial issues that affect your strategic investment decisions.
Calibrated commercial data
Transparent aggregation of datasets
We calibrate different datasets to industry standards and proprietary methodologies which is why Evaluate is trusted and used industry-wide.
Breadth and depth
Cut the data exactly as you need
Use any and all of a huge range of data lenses including global, region, drug, company and therapeutic area.EvaluatePharma:
- Consensus Forecasts to 2026
- Historical Sales from 1986
- Archive Sales Forecasts
- Sales by Indication
- Therapeutic Area
- Orphan Drugs
- Biosimilars
- Mechanism of Action
- Sales, Volume & Pricing USA, Europe, Japan & Brazil
- Company Financials
- Portfolio Analysis
- Patent Risk
- Pipeline Freshness Index
- Venture Financing & IPO
- M&A Analysis
- Company Profiles
- Daily news and Evaluate Vantage
- Drug Profiles
- Tracking Drugs @FDA
- Approvals EMEA
- Uptake Curves
- Expedited Approvals
- Licensing Deals
- Event Analyzer
- R&D Pipeline
- Peer Group Analyzer
- Merge Company
- Customised reporting and easy export
- Integrate reports into workflows via plugins
EvaluatePharma Vision:
- The full EvaluatePharma solution plus:
- Clinical Trials
- Success Rate Benchmarks
- Product Level Probabilities of Success
- First-in-Class
- R&D Costs
- Outcomes
- Timelines
- Calendar of Events
- NPV Analyzer
Add more insights to your pharma subscription
“ Evaluate is not a package I can do without... It's an absolute timesaver, and if you're saving time you're saving money. ”
ANTHONY M, SENIOR DIRECTOR, COMPETITIVE INTELLIGENCE & PROSPECTION, NOVARTIS
“ Evaluate makes it possible for us to assess the commercial value for different products, as well as understand the major trends in the pharmaceutical industry. ”
Dr. HIROHISA NAKADA, ASSOCIATE DIRECTOR, BUSINESS DEVELOPMENT, OTSUKA HOLDINGS